SCHEMBL17469469

SCHEMBL17469469

CNCCN(C)Cc1n[nH]c2ccc(Oc3ccccc3OC)cc12

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ PRMT1 Q99873 11/20 0.37
▸ CARM1 Q86X55 10/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ PRMT3 O60678 1/20 0.35
▸ PRMT6 Q96LA8 1/20 0.35
▸ PRMT8 Q9NR22 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ TTK P33981 1/20 0.34
▸ CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17469512 0.90 PRMT5 (0.37) PRMT5WDR77PRMT1CARM1LRRK2
SCHEMBL17469496 0.89 PRMT1 (0.39) PRMT1CARM1LRRK2PRMT3PRMT6
SCHEMBL17469478 0.89 CARM1 (0.42) PRMT5WDR77PRMT1CARM1LRRK2
SCHEMBL16120045 0.87 TTK (0.39) PRMT1CARM1HTR6TTK
SCHEMBL17469509 0.87 PRMT1 (0.43) PRMT5WDR77PRMT1L3MBTL1HTR6
SCHEMBL17469504 0.87 HTR2A (0.44) PRMT1ALDH1A1L3MBTL1LRRK2HTR6
SCHEMBL17469445 0.87 FADS1 (0.40) PRMT5WDR77PRMT1HTR6ABL1
SCHEMBL17469483 0.86 PRMT1 (0.35) PRMT1CARM1LRRK2
SCHEMBL17469449 0.83 PRMT1 (0.37) PRMT5WDR77PRMT1CARM1ALDH1A1
SCHEMBL17469470 0.82 HSP90AA1 (0.37) PRMT1CARM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2018-04-19 — — US disclosed
US-9765035-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-09-19 — — US disclosed
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT5 3/4885WDR77 92/4885PRMT1 1/4885
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT5 3/4885WDR77 92/4885PRMT1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback